Cutting edge: Activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia

Journal of Immunology

Volumn 168, Issue 12, 2002, Pages 5984-5988

  Verma, Amit ^a   Deb, Dilip K ^a   Sassano, Antonella ^a   Kambhampati, Suman ^a   Wickrema, Amittha ^a   Uddin, Shahab ^a   Mohindru, Mani ^a   Van Besien, Koen ^a   Platanias, Leonidas C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ERYTHROID PRECURSOR CELL; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMYELOCYTE; SIGNAL TRANSDUCTION;

EID: 0037097528     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.12.5984     Document Type: Article

References (25)

1. The pathophysiology of acquired aplastic anemia
2. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia
3. The treatment of severe acquired aplastic anemia
4. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo
5. Circulating activated suppressor T lymphocytes in aplastic anemia
6. γ interferon gene expression in the bone marrow of patients with aplastic anemia
7. Lymphocyte phenotype and lymphokines following antithymocyte globulin therapy in aplastic anemia
8. Further evidence for lymphokine overproduction in severe aplastic anemia
9. Comparative analysis of the influences of human γ, α and β interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells
10. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro
11. Studies of interferon as a regulator of hematopoietic cell proliferation
12. Interferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death
13. Activation of the p38 mitogen activated protein kinase by type I IFNs
14. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon α-dependent transcriptional activation but not serine phosphorylation of Star proteins
15. The p38 MAP kinase pathway mediates the growth inhibitory effects of interferon-α in BCR-ABLexpressing cells
16. Activation of the p38 mitogen activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-β on normal hematopoiesis
17. Engagement of Gab1 and Gab2 in erythropoietin signaling
18. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia
19. + cells of patients with aplastic anaemia
20. Interferon-γ and transforming growth factor-β modulate the activation of mitogen-activated protein kinases and tumor necrosis factor-α production induced by Fcγ-receptor stimulation in murine macrophages
21. Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible pathophysiologic significance
22. 2/M checkpoint after ultraviolet radiation requires p38 kinase
23. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
24. Novel homologues of CSBP/p38 Map kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
25. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket